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Abstract: In a recent genome-wide association study, we participated in the 
identification for the first time of a new locus associated with plasma triglyceride 
concentrations. This loci was at 7q11 near TBL2 (transducin(beta)-like 2) and 
MLXIPL (MLX interacting protein-like or carbohydrate response element binding 
protein) genes. Further studies identified a nonsynonymous SNP (rs3812316, 
G771C, Gln241His) in the MLXIPL gene as the SNP most significantly 
associated with plasma triglycerides. Moreover, its has been suggested that 
MLXIPL is a thrifty gene because the wild-type variant may permit more efficient 
food utilization, fat deposition and rapid weight gain at times of food abundance. 
Therefore our aims were to study the association between the Gln241His in the 
MLXIPL gene with fasting triglycerides and obesity-related variables in a high 
cardiovascular risk Mediterranean population. 
We analyzed 1002 high cardiovascular risk individuals from the PREDIMED-
Valencia Study. Participants (men and women aged 67y) were free of CVD and 
had type 2 diabetes (45%), or three or more CVD risk factors. Genetic, clinical, 
biochemical, anthropometric and life-style data were determined. 
Prevalence of the MLXIPL genotypes were: 85.4% CC, 13.7% GC, 0.9% GG 
(allele frequencies, C=0.923 and G=0.077). Plasma triglyceride concentrations 
were significantly lower in carriers of the G allele (P=0.012). Interestingly, we 
found a consistent association of the SNP with lower BMI. In terms of weight, 
we observed a gene-dosage decreasing effect of this polymorphism: 78+/-13 kg 
(CC), 75+/-12 kg (CG), 66+/-19 kg (GG); P=0.004. This decrease in body-
weight in G-allele carriers was observed in both men and women. 
